To further investigate the biological consequences of TARBP2‐induced Nanog suppression in HCC cells, TARBP2 and Nanog were co‐knocked down in Huh7 cells through sorafenib treatment to detect the level of sorafenib resistance (Fig. 5E,F). The gene discussed is TARBP2; the disease is hepatocellular carcinoma.